# Abbott Laboratories (ABT): MoatMap facts

As of 19 Nov 2026. Research data, not investment advice.

As of 19 Nov 2026, the MoatMap Score for Abbott Laboratories (ABT) is 63/100, ranked against 25,000+ stocks in 38 markets (Quality 63, Value 39, Momentum 57, each scored against its sector).

- MoatMap Score: 63/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 63, Value 39, Momentum 57: each a 0-100 percentile within Healthcare.
- Position: #9,883 overall, #976 in Healthcare.
- Listing: United States, NYQ; Healthcare / Medical Devices.
- Last close: 104.48 USD on 18 Nov 2026.
- Insider filings, last 180 days: directors sold USD 47.3M.
- Buybacks, last 180 days: the company bought back USD 1.4B on 2 days.

Source: https://moatmap.ai/stock/ABT
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker
